Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
16.65
+0.31 (1.90%)
At close: May 22, 2026, 4:00 PM EDT
16.57
-0.08 (-0.48%)
After-hours: May 22, 2026, 7:13 PM EDT
Viatris Employees
Viatris had 30,000 employees as of December 31, 2025. The number of employees decreased by 2,000 or -6.25% compared to the previous year.
Employees
30,000
Change (1Y)
-2,000
Growth (1Y)
-6.25%
Revenue / Employee
$485,420
Profits / Employee
-$9,883
Market Cap
19.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30,000 | -2,000 | -6.25% |
| Dec 31, 2024 | 32,000 | -6,000 | -15.79% |
| Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
| Dec 31, 2022 | 37,000 | 0 | - |
| Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
| Dec 31, 2020 | 45,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Teva Pharmaceutical Industries | 33,950 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,535 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
VTRS News
- 6 days ago - Viatris price target raised to $22 from $17 at Barclays - TheFly
- 7 days ago - Viatris says FDA accepts for review NDA for MR-107A-02 - TheFly
- 7 days ago - U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain - PRNewsWire
- 13 days ago - Viatris Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Viatris price target raised to $20 from $18 at Truist - TheFly
- 17 days ago - Viatris price target raised to $18 from $17 at JPMorgan - TheFly
- 18 days ago - Viatris to Present at the Bank of America Securities 2026 Healthcare Conference - PRNewsWire
- 18 days ago - Viatris beats quarterly estimates on China strength, branded drug sales - Reuters